Literature DB >> 324964

Adverse reactions to rifampicin in antituberculosis regimens.

D J Girling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324964     DOI: 10.1093/jac/3.2.115

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  31 in total

Review 1.  Tuberculosis: 9. Treatment.

Authors:  E Hershfield
Journal:  CMAJ       Date:  1999-08-24       Impact factor: 8.262

Review 2.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors:  Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

Review 4.  Treatment of tuberculosis in newborn infants and their mothers.

Authors:  M C Steinhoff; J Lionel
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

Review 5.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

6.  Intraocular penetration of rifampin after oral administration.

Authors:  K W Wong; D J D'Amico; B S Oum; P A Baker; K R Kenyon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

7.  Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Authors:  Timothy R Sterling; Ruth N Moro; Andrey S Borisov; Elizabeth Phillips; Gillian Shepherd; Newton Franklin Adkinson; Stephen Weis; Christine Ho; Margarita Elsa Villarino
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

Review 8.  Common bacterial infections in infancy and childhood. 1. Respiratory infections.

Authors:  H C Spratt; G A Ahronheim; M I Marks
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

9.  Adverse reactions to rifampicin.

Authors:  D J Girling; K L Hitze
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

10.  [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].

Authors:  E Musch; M Eichelbaum; J K Wang; W von Sassen; M Castro-Parra; H J Dengler
Journal:  Klin Wochenschr       Date:  1982-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.